Unlocking the full potential of liver cells as medicine
Satellite Bio is a Cambridge, Massachusetts-based biotech company pioneering tissue therapeutics. Its proprietary off-the-shelf liver therapy delivers functional hepatocytes into the body to engraft and restore liver function. The company raised $110M across seed and Series A rounds and emerged from stealth in 2022. It uses drug-like manufacturing for scalable, cost-effective global distribution.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account